Evaluating the effect of Doxycycline on biomarkers of oxidative stress in patients with ischemic stroke: a randomized clinical trial study

Early Phase 1

Recruiting

• Conditions: Stroke.; Family history of stroke; Z82.3

• Registration Number: IRCT20170114031921N6
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 March 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Clinical diagnosis of acute hemispheric ischemic stroke
Focal neurological disorder
MRI and CT radiological findings consistent with the clinical diagnosis of acute hemispheric stroke
Absence of other concurrent inflammatory disease

Exclusion Criteria

Available evidence based on acute or chronic intracerebral hemorrhage and cerebral aneurysm
Drug intolerance and side effects

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Malone dialdehyde. Timepoint: One day before starting doxycycline treatment and 7 days after treatment. Method of measurement: It is checked by using ELISA Reed kits and reading the wavelength by variable spectrophotometer.